HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richardson, T. P. Articles by Nugent, M. A. Search for Related Content PubMed PubMed Citation Articles by Richardson, T. P. Articles by Nugent, M. A. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 19, 13534-13540, May 7, 1999

Regulation of Basic Fibroblast Growth Factor Binding and Activity by Cell Density and Heparan Sulfate

From the Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, Boston, Massachusetts 02118

The role of cell density in modulating basic fibroblast growth factor binding and activity was investigated. A primary corneal stromal fibroblast cell culture system was used, since these cells do not constitutively express heparan sulfate proteoglycans in vivo except after injury. A 3-5-fold reduction in bFGF binding per cell was observed as cell density increased from 1000 to 35,000 cells/cm². The cell density-dependent change in bFGF binding was not the result of altered FGFR expression as determined by equilibrium binding experiments and by immunoblot analysis. However, bFGF-cell surface receptor binding affinities were measured to be 10-20-fold higher at low cell densities than at intermediate and high cell density. bFGF-induced cell proliferation was also cell density-dependent, with maximal stimulation of proliferation 190-280% greater at intermediate densities (15,000 cells/cm²) than at other cell densities. This effect was specific to bFGF as serum, epidermal growth factor, and transforming growth factor- did not exhibit the same density-dependent profile. Further, heparan sulfate proteoglycans and, specifically, syndecan-4 were implicated as the modulator of bFGF binding and activity. Pretreatment of cell cultures with heparinase resulted in reduced bFGF binding to the cells and abrogated bFGF induced proliferation. These data suggest a mechanism by which cell density regulates heparan sulfate proteoglycan expression and modulates the cellular response to bFGF. Modulation of heparan sulfate proteoglycan expression might be an important aspect of the regulation of stromal cell migration and proliferation during wound healing.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J K Shute, N Solic, J Shimizu, W McConnell, A E Redington, and P H Howarth Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma Thorax, July 1, 2004; 59(7): 557 - 562. [Abstract] [Full Text] [PDF]

				S. Q. Liu, D. Tang, C. Tieche, and P. K. Alkema Pattern formation of vascular smooth muscle cells subject to nonuniform fluid shear stress: mediation by gradient of cell density Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1072 - H1080. [Abstract] [Full Text] [PDF]

				H. Joensuu, A. Anttonen, M. Eriksson, R. Makitaro, H. Alfthan, V. Kinnula, and S. Leppa Soluble Syndecan-1 and Serum Basic Fibroblast Growth Factor Are New Prognostic Factors in Lung Cancer Cancer Res., September 15, 2002; 62(18): 5210 - 5217. [Abstract] [Full Text] [PDF]

				Q H Song, V E Klepeis, M A Nugent, and V Trinkaus-Randall TGF-{beta}1 regulates TGF-{beta}1 and FGF-2 mRNA expression during fibroblast wound healing Mol. Pathol., June 1, 2002; 55(3): 164 - 176. [Abstract] [Full Text] [PDF]

				R. L. Stephen, L. E. Shaw, C. Larsen, D. Corcoran, and P. D. Darbre Insulin-like Growth Factor Receptor Levels Are Regulated by Cell Density and by Long Term Estrogen Deprivation in MCF7 Human Breast Cancer Cells J. Biol. Chem., October 19, 2001; 276(43): 40080 - 40086. [Abstract] [Full Text] [PDF]

				R. Landry, V. Rioux, and A. Bensadoun Characterization of Syndecan-4 Expression in 3T3-F442A Mouse Adipocytes: Link between Syndecan-4 Induction and Cell Proliferation Cell Growth Differ., October 1, 2001; 12(10): 497 - 504. [Abstract] [Full Text] [PDF]

				K. R. Stenmark Cell-, age-, and phenotype-dependent differences in the control of gene expression Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L762 - L765. [Full Text] [PDF]

				M. C. Dechecchi, P. Melotti, A. Bonizzato, M. Santacatterina, M. Chilosi, and G. Cabrini Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5 J. Virol., September 15, 2001; 75(18): 8772 - 8780. [Abstract] [Full Text] [PDF]

				V. E. Klepeis, A. Cornell-Bell, and V. Trinkaus-Randall Growth factors but not gap junctions play a role in injury-induced Ca2+ waves in epithelial cells J. Cell Sci., January 12, 2001; 114(23): 4185 - 4195. [Abstract] [Full Text] [PDF]

				T. Richardson, V Trinkaus-Randall, and M. Nugent Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin J. Cell Sci., January 5, 2001; 114(9): 1613 - 1623. [Abstract] [PDF]

				E. B. Izevbigie and W. G. Bergen {beta}-Adrenergic Agonist Hyperplastic Effect Is Associated with Increased Fibronectin Gene Expression and Not Mitogen-Activated Protein Kinase Modulation in C2C12 Cells Experimental Biology and Medicine, March 1, 2000; 223(3): 302 - 309. [Abstract] [Full Text]